VEGF-SPECT with ¹¹¹In-bevacizumab in stage III/IV melanoma patients.
Nagengast WB, Hooge MN, van Straten EM, Kruijff S, Brouwers AH, den Dunnen WF, de Jong JR, Hollema H, Dierckx RA, Mulder NH, de Vries EG, Hoekstra HJ, Hospers GA.
Nagengast WB, et al. Among authors: kruijff s.
Eur J Cancer. 2011 Jul;47(10):1595-602. doi: 10.1016/j.ejca.2011.02.009. Epub 2011 Mar 21.
Eur J Cancer. 2011.
PMID: 21429739